CPT1B and Insulin resistance: Both cases support the concept that decreased intramyocellular acylcarnitine can ameliorate insulin resistance, which is consistent with the significantly increased acylcarnitine level in the muscle of insulin resistant Cpt1b+/−mice after prolonged HFD feeding.